SBRA SABRA HEALTH CARE REIT
Real Estate · Russell 2000
Next earnings: not announced yet
What 18 analyst firms say about SABRA HEALTH CARE REIT: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
18 rated views · 20 analyst/firm records · 18 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8033
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8065
Recent analyst activity · last 90 days
Our tracked history has 10 reports on SBRA from 9 analyst firms in the last 90 days (19 firms in the past year).
Comparing each firm's latest target with its previous one: 3 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wells Fargo lowered its target from $23.00 (set 1 Jun 2026) to $21.00 on 19 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Vikram Malhotra | Hold | 31 Aug 2026 | 21.00 USD |
| Baird | Wesley Golladay | Hold | 31 Aug 2026 | 23.00 USD |
| Barclays | Richard Hightower | Hold | 13 Oct 2026 | 21.00 USD |
| BMO Capital Markets | John P Kim | Hold | 11 May 2026 | 25.00 USD |
| Cantor Fitzgerald | Richard C Anderson | Hold | 10 Aug 2026 | 22.00 USD |
| Citigroup | Nicholas Joseph | Buy | 22 Jul 2026 | 19.00 USD · 22 Jun 2026 |
| Citizens JMP | Aaron Hecht | Buy | 22 Jul 2026 | 25.00 USD |
| Deutsche Bank | Unnamed analyst | Buy | 22 Jul 2026 | — |
| Huntington | Unnamed analyst | Buy | 10 Sep 2026 | 23.00 USD |
| Huntington Securities | Robert C Stevenson | Buy | 2 Nov 2026 | 23.00 USD |
| Jefferies | Joe Dickstein | Buy | 15 Jul 2026 | 22.00 USD |
| KeyBanc Capital Markets | Austin Wurschmidt | Hold | 21 Jul 2026 | — |
| Raymond James | David Rodgers | ConflictConflicting reports · excluded | 6 Aug 2026 | — |
| Scotiabank | Nicholas Yulico | Hold | 18 Jun 2026 | Conflicting reports · excluded |
| Truist | Michael Lewis | Buy | 22 Jul 2026 | 24.00 USD |
| UBS | Michael Goldsmith | Hold | 13 Oct 2026 | 20.00 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | James Feldman | Buy | 19 Oct 2026 | 21.00 USD |
| Wells Fargo | John Kilichowski | Buy | 19 Oct 2026 | 21.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:39 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.